Raymond James & Associates’s 23andMe Holding Co ME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$26.3K Hold
3,781
﹤0.01% 3923
2024
Q2
$29.6K Sell
3,781
-500
-12% -$4.79K ﹤0.01% 3852
2024
Q1
$45.5K Buy
4,281
+982
+30% +$12.6K ﹤0.01% 3814
2023
Q4
$60.3K Buy
3,299
+1,490
+82% +$25.8K ﹤0.01% 3690
2023
Q3
$35.4K Buy
1,809
+962
+114% +$27K ﹤0.01% 3696
2023
Q2
$29.6K Buy
847
+255
+43% +$10.2K ﹤0.01% 3750
2023
Q1
$27K Buy
592
+19
+3% +$917 ﹤0.01% 3777
2022
Q4
$24.8K Sell
573
-451
-44% -$26.3K ﹤0.01% 3777
2022
Q3
$59K Buy
1,024
+314
+44% +$20.6K ﹤0.01% 3687
2022
Q2
$35K Sell
710
-1,304
-65% -$75.6K ﹤0.01% 3831
2022
Q1
$154K Buy
2,014
+193
+11% +$17.6K ﹤0.01% 3737
2021
Q4
$243K Buy
1,821
+1,028
+130% +$190K ﹤0.01% 3575
2021
Q3
$144K Sell
793
-309
-28% -$54.9K ﹤0.01% 3755
2021
Q2
$258K Buy
1,102
+273
+33% +$56.8K ﹤0.01% 3534
2021
Q1
$169K Buy
+829
New +$202K ﹤0.01% 3660

Other funds holding ME

Raymond James & Associates's ME Position: Q3 2024 in Review

Raymond James & Associates held its 23andMe Holding Co (ME) position steady in Q3 2024 at 3,781 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3923.

Raymond James & Associates first reported a position in ME in Q1 2021 and has held it in 15 quarters since. The position peaked at $258K in Q2 2021. 116 funds tracked by Wall St. Rank hold ME as of Q3 2024.

  • Raymond James & Associates held 3,781 shares of 23andMe Holding Co worth $26.3K as of Q3 2024.
  • Raymond James & Associates left its 23andMe Holding Co share count unchanged in Q3 2024.
  • 23andMe Holding Co made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3923 holding.
  • Raymond James & Associates first reported a position in 23andMe Holding Co in Q1 2021 and has held it in 15 quarters since.
  • Raymond James & Associates's 23andMe Holding Co position peaked at $258K in Q2 2021.
  • 116 funds tracked by Wall St. Rank held 23andMe Holding Co as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.